Esperion(ESPR) - 2021 Q4 - Earnings Call Transcript

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2021 Earnings Conference Call February 22, 2022 8:00 AM ET Company Participants Ben Church - Investor Relations & Corporate Communications Sheldon Koenig - President & Chief Executive Officer Rick Bartram - Chief Financial Officer Eric Warren - Head of Sales and Marketing Joanne Foody - Chief Medical Officer Betty Jean Swartz - Senior Vice President Market Access, HEOR & Policy Conference Call Participants Michael Yee - Jefferies Joseph Thome - Cowen and Company ...